Your browser doesn't support javascript.
loading
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
Tang, Yu Hin; Rockstroh, Anja; Sokolowski, Kamil A; Lynam, Layla-Rose; Lehman, Melanie; Thompson, Erik W; Gregory, Philip A; Nelson, Colleen C; Volpert, Marianna; Hollier, Brett G.
Affiliation
  • Tang YH; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
  • Rockstroh A; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
  • Sokolowski KA; Preclinical Imaging Facility, Translational Research Institute, Brisbane, QLD, Australia.
  • Lynam LR; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
  • Lehman M; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
  • Thompson EW; School of Biomedical Sciences, Faculty of Health and Translational Research Institute, Queensland University of Technology, Brisbane, Australia.
  • Gregory PA; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia.
  • Nelson CC; Faculty of Health and Medical Sciences, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
  • Volpert M; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
  • Hollier BG; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD,
Breast Cancer Res ; 24(1): 8, 2022 01 25.
Article in En | MEDLINE | ID: mdl-35078508
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Year: 2022 Type: Article